22-25th June 2026: At this year’s annual meeting of the Bio International Convention (BIO) in San Diego, CA, TechBio company Cytomos (www.cytomos.com) is showcasing their flagship cell analytic intelligence platform AuraCyt® – together with its novel benchtop technology Celledonia® – which is set to revolutionise predictive cell analytics.
Current challenges in the bioprocessing space include slow, label-dependent analytical methods that are inefficient to scale-up and provide limited predictive insight.
The Cytomos AuraCyt® platform unlocks the power of predictive cell intelligence, by measuring intrinsic cell physics to generate AI-ready digital fingerprints that reveal the true multi-dimensional state and behaviour of the cell.
The showcase benchtop cell analytics intelligence system combines the compact Celledonia® analyser with the precision silicon sensors of the AuraCyt® modules, powering the AuraCyt® Analysis Suite to transform complex cellular data into actionable insights.
This rapid, label-free, single-cell analysis system predicts future productivity, stability and manufacturability, enabling earlier insights and real-time decision-making, lowering risk, providing scalable impact, optimising process and improving product consistency.
This provides demonstrable value across various applications, such as reducing CLD timelines by up to 40%, saving up to 65% of resources in lentivirus batch production, and reducing CAR-T process time by up to 30%.
Cytomos is showcasing this novel technology at its pod in BIO Business Forum Zone D (Exhibit Hall 2221 UK Pavillion), from 22-25th of June, 2026. BIO International is the world’s largest biotechnology gathering, bringing together thousands of leaders across the global life sciences community from academia, industry, and finance to showcase breakthrough technologies.
To download the full press release in PDF format please click here.
18 June 2026
[gravityform id="1" title="false"]